Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TN0A
|
|||
| Former ID |
DNC004658
|
|||
| Drug Name |
1-Oxazolo[4,5-b]pyridin-2-yl-6-phenyl-hexan-1-one
|
|||
| Synonyms |
PHOP; 288862-83-9; CHEMBL175854; 1-(oxazolo[4,5-b]pyridin-2-yl)-6-phenylhexan-1-one; 1-Oxazolo[4,5-b]pyridin-2-yl-6-phenyl-hexan-1-one; SCHEMBL3964367; CTK8E9849; LEI-104; DTXSID10435440; MolPort-009-018-760; HMS3649E22; ZINC13611906; BDBM50161518; ACM288862839; RT-015038; SR-01000946606; J-017316; SR-01000946606-1
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H18N2O2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CCCCCC(=O)C2=NC3=C(O2)C=CC=N3
|
|||
| InChI |
1S/C18H18N2O2/c21-15(18-20-17-16(22-18)12-7-13-19-17)11-6-2-5-10-14-8-3-1-4-9-14/h1,3-4,7-9,12-13H,2,5-6,10-11H2
|
|||
| InChIKey |
VPZHQLPAKFVGKX-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 288862-83-9
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. J Med Chem. 2005 Aug 11;48(16):5059-87. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.